Overview
Large granular lymphocytic (LGL) leukemia is a rare lymphoproliferative disorder characterized by clonal expansion of either T cells or natural killer (NK) cells, often presenting as indolent but potentially aggressive hematologic malignancies 1.Diagnosis
Clinical Presentation: May include splenomegaly, neutropenia, and extramedullary manifestations such as leg ulcers and telangiectasias 1.
Laboratory Tests: Clonal expansion of LGL cells in peripheral blood or bone marrow, often with specific markers like CD56(-) for NK-cell lineage 1.
Imaging and Biopsy: Skin biopsies may reveal infiltration by LGL cells, aiding in diagnosis 1.
Differential Diagnosis: Consider Felty syndrome, especially in patients with rheumatoid arthritis, but distinguish by specific LGL markers and clinical features 1.Management
First-Line Treatments: No specific first-line treatment universally recommended; management often focuses on symptom control and supportive care 12.
Adjunctive Therapies: Farnesyltransferase inhibitors like tipifarnib have shown promise in improving hematopoiesis and specific clinical manifestations (e.g., pulmonary artery hypertension) 2.
Targeted Approaches: Disrupting imbalanced NK-receptor signaling pathways may be beneficial in selected cases 2.Special Populations
Elderly Patients: Case reports highlight the condition in elderly patients, emphasizing the need for careful monitoring and tailored supportive care 1.
Comorbidities: Patients with comorbidities like rheumatoid arthritis may present with complex clinical pictures requiring multidisciplinary management 1.Key Recommendations
Consider LGL leukemia in the differential diagnosis for elderly patients with rheumatoid arthritis, splenomegaly, and unexplained neutropenia, especially when cutaneous manifestations are present (Evidence: Moderate 1).
Evaluate for clonal LGL cell populations in peripheral blood or bone marrow to confirm diagnosis, utilizing specific markers like CD56 status 1.
Explore targeted therapies such as farnesyltransferase inhibitors for patients with LGL leukemia presenting with hematological complications like pulmonary artery hypertension (Evidence: Weak 2).References
1 Duarte AF, Nogueira A, Mota A, Baudrier T, Canelhas A, Cancela J et al.. Leg ulcer and thigh telangiectasia associated with natural killer cell CD56(-) large granular lymphocyte leukemia in a patient with pseudo-Felty syndrome. Journal of the American Academy of Dermatology 2010. link
2 Epling-Burnette PK, Sokol L, Chen X, Bai F, Zhou J, Blaskovich MA et al.. Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood 2008. link